Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG)

Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 10 best healthcare equipment stocks to buy according to hedge funds.

On January 27, Freedom Capital increased the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $560 to $610, and also upgraded its rating on the stock from Hold to Buy. The upward revision in the target price now leads to more than 11% upside potential at the prevailing level.

The firm attributed its rating upgrade on Intuitive Surgical, Inc. (NASDAQ:ISRG) to the elevated topline forecast for the next 2 years. It sees the launch of da Vinci 5 as a key driver of the company’s system sales and procedure volumes during 2026.

On January 26, the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) was raised from $686 to $712 by Matt Miksic from Barclays. The analyst also maintained his Overweight rating on the stock, which offers a revised upside potential of almost 42%. Miksic shared these revisions after the company’s fourth quarter announcements. He noted that management’s 2026 forecasts appear similar to prior estimates.

Intuitive Surgical, Inc. (NASDAQ:ISRG) operates within the robotic-assisted surgery market. The company is involved in the manufacturing and marketing of products that facilitate minimally invasive care, ensuring improved quality and access. Its flagship offerings are the da Vinci Surgical System and the Ion endoluminal system.

While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.